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PURPOSE. The purpose of this study was to develop a more efficient drug delivery device to
overcome the limitations of current drop therapy for the treatment of fungal keratitis.
METHODS. Amphotericin B (AmpB), 0 to 30 lg/mL, was associated with a poly-e-lysine (peK)
hydrogel. Fungicidal effect against Candida albicans was assessed at 18 and 42 hours by
optical density (OD600) and growth on agar. Tear film dilution effect was mimicked by storage
of AmpB peK gels in 3.4 mL sterile PBS for 24 hours prior to fungal incubation. Drug elution
over 96 hours was evaluated by HPLC, and drug stability was tested while associated with the
gel by OD600 up to 48 hours. Lack of cytotoxicity toward the HCE-T corneal epithelial cell line
was assessed over 7 days.
RESULTS. AmpB peK gels show fungicidal activity in normal conditions (0.057 OD600, SD 0.003,
P < 0.005) and in the presence of horse serum (0.048 OD600, SD 0.028 P < 0.005) at 18
hours. The drug release profile was above therapeutic levels (0.188 lg/mL) for up to 72
hours. Tear dilution had no significant effect at higher concentrations of AmpB (3 to 10 lg/
mL). AmpB peK gels were not cytotoxic to the HCE-T cell line.
CONCLUSIONS. We demonstrated that AmpB peK gels confer sustained therapeutic antifungal
activity for at least 48 hours without corneal epithelial cell line cytotoxicity, suggesting their
potential for in vivo use as an antifungal bandage contact lens. This could avoid the need for
intensive topical medication in the treatment of fungal keratitis.
Keywords: hydrogel, drug delivery, antimicrobial, amphotericin, bandage lens, cornea,
keratitis
Fungal keratitis (Fig. 1a) is a challenging condition to treat.Despite intensive topical antifungal therapy, it is not
uncommon for systemic antifungal medication and emergency
tectonic corneal grafts to be necessitated. The associated severe
inflammation and scarring often leads to some permanent loss
of vision, and if the infection is not controlled, it may lead to
endophthalmitis.1
There are two types of fungi that cause fungal keratitis:
filamentous fungi such as Fusarium and Aspergillus spp. and
yeast-like fungi such as Candida. Filamentous fungal keratitis
tends to occur because of trauma involving vegetative matter.2
Candida infections are more common in those with preexist-
ing ocular surface disease, such as severe dry eye and/or
exposure; topical steroid use; postocular surgery; or those with
other systemic risk factors such as diabetes or immunosup-
pression.3
The mainstay of treatment for fungal keratitis is the use of
topical antifungal drops. However, their efficacy is limited, with
the majority of the drop immediately draining down the cheek
or the nasolacrimal duct.4 The remainder is subject to
nonspecific absorption and is continuously diluted by the tear
film and reflex tearing or dispersed by blinking.5,6 Typically,
only 1% to 7% of the drug reaches the target tissue, and only a
fraction will penetrate the deep layers of the corneal stroma
where fungal infections may extend.5,7–9 To overcome these
limitations, prolong contact time with the cornea, and achieve
therapeutic stromal drug concentrations, regular (hourly or
half-hourly) instillation of drops is required.7 Although drop
frequency decreases as the infection improves, regimes
typically last for months.2,10 Unsurprisingly, patient compliance
is problematic.11 Therefore, a drug release system that delivers
sufficient quantities of drug to the cornea while increasing the
contact time would improve drug efficacy, improve patient
compliance, and limit the demands on nursing care.
A therapeutic contact lens is an ideal option for sustained-
release drug delivery as it sits directly on the cornea and could
help to limit tear dilution behind the lens and enable prolonged
drug contact time with the tissue.12,13 A contact lens also
provides protection to the cornea and may reduce associated
pain. Furthermore, local drug concentrations could be supple-
mented by the addition of topical drug therapy.14–16
Poly-e-lysine (peK) hydrogels are fully synthetic, transparent,
high-water-content (70%) peptide gels manufactured using
carbodiimide chemistry to cross-link the naturally occurring
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components peK and bis-carboxylic fatty acids (Fig. 1b). The
high water content ensures excellent oxygen transmission to
the avascular cornea reducing the risk of corneal hypoxia and
vascularisation.17 The mechanical properties and optical
transparency of these gels can be easily optimized by altering
the cross-link density, the polymer density, and the molecular
length of the bis-carboxylic fatty acid cross-linker. We
demonstrated that peK gels are noncytotoxic to a human
corneal epithelial cell line (HCE-T).18 Furthermore, the amine
functional groups in the polymer backbone can be used for the
chemical attachment of a range of biomolecules to aid drug
delivery. Amphotericin B (AmpB) is one of the first-line
therapies against C. albicans keratitis.19 AmpB contains a 38-
member lactone ring with amino and carboxyl moieties.20,21
These carboxyl moieties have the potential to interact with
amine groups on peK within the polymer matrix.
This study aimed to modify a peK hydrogel (Su 60 15;
octanedioic acid cross-linker with a density of 0.066 g/mL and
60 mol% cross-linked) by associating AmpB with the amine
functional groups to provide an effective drug delivery
mechanism against C. albicans under different growth
conditions. An investigation of AmpB stability after associating
it with the hydrogel and the subsequent toxicity of the AmpB
hydrogels toward the HCE-T cell line was also investigated.
MATERIALS AND METHODS
Poly-e-lysine, octanedioic acid, n-methylmorpholine (NMM), 1-
ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDCI), and n-
hydroxysuccinimide (NHS) were supplied by SpheriTech Ltd.
(Runcorn, UK). HCE-T cells were donated by Kaoru Araki-
Sasaki (Itami City, Japan).22 All other reagents including AmpB
(A2942, 250 lg/mL) stock were supplied by Sigma Aldrich
(Gillingham, UK) unless otherwise stated.
Preparation of Hydrogel Su 60 15
Hydrogel Su 60 15 (30 mL) with 60% cross-linking and a
polymer density of 0.07 g/mL was prepared. PeK (2.077 g) was
dissolved in sterile distilled water (7.5 mL) in a 15-mL Falcon
tube (Starlab Ltd., Blakelands, UK). An aliquot of 5% Tween 80
(0.25 mL) was added. Octanedioic acid (0.631 g) was dissolved
in sterile distilled water (6.125 mL) with NMM (1.325 mL). This
was sonicated until dissolved and added to the peK solution.
NHS and EDCI were measured into two separate 15-mL Falcon
tubes and dissolved in PBS (7.5 mL PBS; Oxoid Ltd.,
Hampshire, UK). All solutions were filtered in a class II
microbiology hood using a 0.2-lm syringe filter. EDCI (3.471 g)
and NHS (0.695 g) were mixed together and immediately
added to the peK/octanedioic acid solution. This was inverted
five times. An aliquot of the polymer solution (5 mL) was
pipetted into 63-cm2 nontreated tissue culture dishes (Greiner
Bio-One GmbH, Kremsmu¨nster, Austria). These were incubat-
ed for at least 5 hours at room temperature until the gel had
polymerized, followed by addition of PBS to prevent dehydra-
tion of the gel. Sheets of gel were washed five times with 10%
NMM for 5 minutes, followed by thorough washing in dH2O
(10 3 5 minutes) to remove excess NMM. Gels were
subsequently sterilized in 70% ethanol overnight before
washing five times in sterile PBS and using them for
experiments. Prior to commencing experiments, gels were
cut into circular discs (0.36 cm2) using a metal trephine.
Culture of C. albicans
C. albicans strain SC5314 was revived from 808C storage on
potato dextrose agar (PD-agar; Formedium Ltd., Norfolk, UK)
streak plates incubated at 378C overnight.23 C. albicans was
subcultured by inoculating a PD agar streak plate with one
colony taken from a previous PD agar plate and incubated
overnight at 378C. Colonies were maintained on PD agar stored
at 58C. Broth cultures were initiated by inoculating PD media
(10 mL) with one colony of C. albicans taken from a PD agar
plate. Cultures were incubated overnight at 378C with constant
shaking at 100 rpm. These were subcultured by taking an
aliquot of C. albicans broth culture (0.5 mL) and diluting it in
sterile PD broth (10 mL). For experiments, overnight broth
culture (0.5 mL) was diluted with PD broth (10 mL), and
optical density readings at 600 nm (OD600) were measured
hourly with a Jenway 6705 UV/Vis Spectrophotometer (Bibby
Scientific Ltd., Staffordshire, UK). An initial OD600 measured
between 0.1 and 0.2 and was monitored until an OD600 0.5 to
0.6 was obtained. The culture was diluted 1:1 with sterile PD
prior to experiments. Candida cultures were dispersed in an
ultrasonic bath for 15 minutes prior to experiments to prevent
aggregation.
Fungicidal Effects of AmpB-Loaded Gel
AmpB (250 lg/mL) was diluted in sterile PBS to concentrations
of 30, 25, 20, 15, 10, 5, 3, and 0 lg/mL. Gels were incubated in
the various concentrations of AmpB for 2 hours before being
transferred to 96-well microtiter plates. Control wells contain-
ing PD only and PD with C. albicans were used throughout all
these experiments. Wells containing PD (0.1 mL) were
FIGURE 1. (a) Clinical photograph of fungal keratitis. Image courtesy of Stephen B. Kaye. (b) Example bandage contact lens material cast from
hydrogel Su 60 14 (octanedioic acid cross-linker with a density of 0.071 g/mL and 60 mol% cross-linked).
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inoculated with C. albicans (0.0125 mL). Microtiter plates
were incubated overnight at 378C, and OD600 readings were
taken after 18 hours (Fig. 2, step 1).
This protocol was repeated to include C. albicans with the
addition of horse serum (10% vol/vol) to PD broth to promote
differentiation and upregulate the expression of virulence
genes.24,25 After the gels were removed from the microtiter
plate, they were individually washed in sterile PBS (5 mL) to
remove any loosely attached fungi, and the wash solution was
collected (Fig. 2, step 2). The gels were extracted using sterile
forceps and placed on PD agar plates to identify the presence
of viable fungi. An aliquot of each PBS wash solution (0.02 mL)
was also plated (Fig. 2, step 2). The agar plates were incubated
at 378C overnight before imaging and counting the colony-
forming units (Fig. 2, step 3). After the gels were removed, the
plates were incubated at 378C for a second night to establish
whether there was any further growth of C. albicans. OD600
readings were taken after 24 hours (Fig. 2, step 3).
Fungicidal Effect of the AmpB-Loaded Gel After 24-
Hour Storage in PBS
Discs (0.36 cm2) of gel were incubated in various concentra-
tions of AmpB (0.3, 3, 5, and 10 lg/mL) for 2 hours.
Subsequently, the gel samples were individually incubated in
3.4 mL sterile PBS for 24 hours to mimic and assess the dilution
effect of the tear film in vivo. Gels were then transferred to a
96-well microtiter plate containing PD (0.1 mL), and the PBS
tear film solution was collected. The gels were inoculated with
C. albicans (0.0125 mL) and incubated at 378C overnight.
OD600 readings were taken after 18 hours with and without
gels in the microtiter plate. After removal from the microtiter
plate, gels were individually washed as described previously.
The gels and an aliquot of the tear film wash solutions (0.02
mL) were plated onto PD agar. The agar plates were incubated
at 378C overnight before imaging, and the number of colony-
forming units was determined.
An aliquot of each PBS tear film solution (0.1 mL) was
diluted with PD (0.1 mL) and added to a 96-well microtiter
plate. The microtiter plate was then inoculated with C.
albicans (0.0125 mL) and incubated overnight at 378C.
OD600 readings were taken after 18 hours.
AmpB Elution From the Hydrogel
Discs of the gel (0.36 cm2) were incubated in a 30-lg/mL
AmpB solution for 2 hours. The gels were removed and
incubated in PBS at one gel per 0.1 mL for 24, 48, 72, and 96
hours. At each time point, the supernatant was removed and
used to monitor AmpB elution via HPLC. Fresh PBS was added
to the same gel samples prior to reincubation.
Reversed-phase HPLC (RP-HPLC) was performed on a
SpectraSYSTEM AS3000 (Thermo Scientific, Waltham, MA,
USA) with a C18 Vydac column (4.6 3 250 mm, 5 lm). The
column temperature was set at room temperature, and 0.2 mL
was the injection volume at a flow rate of 1 mL/min. The
gradient was set to 40% to 100% B over 15 minutes with A:
0.1% TFA in H2O, B: 0.1% trifluoroacetic acid (TFA) in MeCN
and a detection wavelength of 380 nm.
AmpB Stability While Associated With the
Hydrogel
Discs of the gel (0.36 cm2) were incubated in a 30-lg/mL
AmpB solution for 2 hours. The gel was removed and
incubated without media at 258C for 1, 24, or 48 hours. The
AmpB incubation solution was also stored for the same period.
PD (0.1 mL) was added to each test well in a 96-well microtiter
plate, and then a test gel or the corresponding AmpB
incubation solution was added (0.0125 mL) and inoculated
with C. albicans (0.0125 mL). Microtiter plates were incubated
FIGURE 2. Schematic highlighting the various stages involved in monitoring the antifungal activity of hydrogel Su 60 15. Step 1: PeK gels were
incubated with AmpB for 2 hours and then incubated overnight with C. albicans. Step 2: The optical density, OD600, of C. albicans growth was
measured; the gels were removed from the wells, washed in PBS to remove loosely adhered cells, and then placed on PD agar; and 0.02-mL samples
of the PBS washes were pipetted onto PD-agar. Step 3: After another overnight incubation, further OD600 readings, counts of colony forming units,
and images were taken.
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overnight at 378C, and OD600 readings were taken after 18
hours.
Cytotoxicity of AmpB-Loaded Gels
A cell counting kit-8 (CCK-8) assay kit (Dojindo Laboratories,
Kumamoto, Japan) was used to monitor AmpB gel cytotoxicity
toward the HCE-T cell line. Discs of the gel (0.36 cm2) were
incubated in a 30-lg/mL AmpB solution for 2 hours prior to
incubating one gel per 0.1 mL in DMEM/F12 cell culture media
at 378C for 3 days. Media without gels was also incubated for
the same period as a control. HCE-T cells were then seeded at a
density of 2.53 104 in a 48-well microtiter plate and incubated
with media from the preincubation with the gels or the control
media (0.25 mL). At time points 4, 24, 48, 96, and 168 hours,
CCK-8 (0.025 mL) was added to each well and incubated at
378C for 2 hours. Aliquots (230.1 mL) of media were removed
and transferred to a 96-well microtiter plate, and the
absorbance was read at 485 nm on a FLUOstar Omega
microplate reader (BMG LABTECH GmbH, Ortenberg, Ger-
many).
Statistical Analysis
GraphPad Prism version 5.03 for Windows (GraphPad Soft-
ware, San Diego, CA, USA) was used to model 2-way univariate
ANOVA with Tukey post hoc analysis, as well as model 1-way
univariate ANOVAs to analyze data at the same concentrations
or time points where appropriate. All the statistical data were
presented as means 6 SD.
RESULTS
Fungicidal Effects of AmpB-Loaded Gels
The loading of AmpB and its release from the gels significantly
reduced the growth of C. albicans compared with no AmpB,
with no obvious changes in transparency (Fig. 3). However,
there was no statistically significant difference between
concentrations of AmpB or between the different culture
conditions (-NH2, -NH2 gel cultured in PDþ 10% horse serum)
compared across all concentrations.
Viability of Cells Attached or Loosely Adhered to
the Gel
No loosely attached viable fungi were recovered from the gel
wash. Minimal Candida growth was also observed when gels
preincubated with AmpB (0.3 lg/mL) were placed directly on
PD agar (Fig. 4).
Viability of Fungi Remaining in the Wells
No further growth of C. albicans was observed in wells that
previously contained the gel across all AmpB preincubation
concentrations (Fig. 5).
Fungicidal Effect of AmpB-Loaded Gels After
Storage in PBS
A statistically significant decrease in the growth of C. albicans
was measured in wells treated with 3 to 10 lg/mL AmpB
compared with those treated with 0.3 lg/mL (Fig. 6).
FIGURE 3. Bar chart demonstrating the fungicidal effects of gels
preincubated in various concentrations of AmpB under different
growth conditions. Error bars denote 6SD, ***P < 0.005, N¼ 9.
FIGURE 4. C. albicans viability assays on gels and from PBS washes with enhanced images of representative wells for each sample. (I) Gels plated on
PD agar for 0þ3 lg/mL AmpB gel cultured in PD broth and PD broth supplemented with 10% horse serum. (II) Washes plated on PD agar for 0þ 3
lg/mL AmpB gel cultured in PD broth and PD broth supplemented with 10% horse serum.
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AmpB Elution From the Gels
A therapeutic dose of AmpB (see Supplementary Material S1)
was eluted from the gel for a period of 72 hours with a smaller
dose after 96 hours (Fig. 7). The dose at 96 hours is still
relevant compared with minimum inhibitory concentration
data from the literature.26,27
AmpB Viability After Attachment to the Hydrogels
AmpB associated with the hydrogel remained stable and
produced a killing effect against C. albicans for at least 48
hours (Fig. 8). There seemed to be less C. albicans killed at 48
hours compared with the earlier time points; however, this was
not statistically significant. There was no difference between
the efficacy of the AmpB gels and the 30-lg/mL AmpB
incubation solution at each time point in terms of the
eradication of C. albicans.
Cytotoxicity of AmpB Gels
No cytotoxicity to the HCE-T cell line was observed when
comparing gels incubated in AmpB (30 lg/mL) with standard
cell culture media (Fig. 9). The positive control (Su PeK PO4), a
Su 60 14 gel loaded with phosphate, was cytotoxic toward the
HCE-T cell line as already determined for this cell line.18
DISCUSSION
Development of a bandage contact lens as a drug delivery
device for antifungal drugs overcomes the limitations of topical
antifungal eye drops, with great potential benefit in the
management of fungal keratitis. Ideally a bandage contact lens
may be worn for extended periods of time, aiding ocular
surface healing and comfort with less frequent need for
medical review and lens change. The lens material in this
situation must have excellent oxygen permeability to preserve
the integrity of the avascular cornea. High-water-content
hydrogels would allow significant oxygen permeability through
the water phase of the gel. The advantage of hydrogels for drug
delivery is the potential to incorporate biomolecules through-
FIGURE 5. Investigation of further growth of C. albicans in wells that
contained gels preincubated in different concentrations of AmpB;
OD600 after 18 hours with gels removed compared with OD600 after a
further 24-hour incubation. Error bars denote 6SD. *P < 0.05, N¼ 6.
FIGURE 6. Antifungal effects of gels preincubated in various concen-
trations of AmpB prior to overnight storage in 3.4 mL sterile PBS tear
film solution. Error bars denote 6SD. *P < 0.05, **P < 0.01, ***P <
0.005, N¼ 3.
FIGURE 7. AmpB elution from gels over a 96-hour period as measured
by RP-HPLC. Line denotes the MIC for C. albicans determined in this
report (Supplementary Material). Error bars denote 6SD. ***P <
0.001, N ¼ 4.
FIGURE 8. Effectiveness of AmpB gels at killing C. albicans after
preincubation for set time points. Error bars denote 6SD, ***P <
0.001, N ¼ 6.
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out the gel during synthesis or attachment via charged
functional groups after polymerization.
A hydrogel was synthesized from peK and octanedioic acid
using carbodiimide chemistry that was transparent, had similar
mechanical properties to existing hydrogel contact lenses, and
had a water content in the order of 70% that yields an oxygen
permeability comparable to other short-term wear hydrogel
lenses.18 Its excellent transparency would allow an ophthalmic
review of the cornea without having to remove the lens, and
this feature does not appear to be altered with the addition of
AmpB. These hydrogels can be manufactured reproducibly and
in an environmentally friendly way because they gel from
aqueous solutions at room temperature requiring no harsh
solvents, such as those used in the production of silicone
hydrogel contact lenses. Furthermore, the mechanical and
surface chemical properties can be tuned to optimize the
mechanical properties and the number and character of the
surface functional groups. We produced a lens material that has
a 60% cross-link density using a peK density of 0.07 g/mL (Su
60 15). This hydrogel has a positive charge due to the
remaining uncross-linked amine groups within the polymer
matrix.
C. albicans strain SC5314 was used to model a fungal
keratitis infection as it is the most well-studied strain of
Candida and is the organism that is most common in
temperate climates.2 AmpB was used as the antifungal agent,
given that it is one of the first-line choices against C. albicans
and has a carboxyl group that can promote attachment of the
drug molecule to the free amine groups on hydrogel Su 60 15
and aid its uptake into the hydrogel.19,21 The MIC found in this
report (see Supplementary Material S1) is between 0.094 and
0.188 lg/mL for C. albicans cultured in both PD and PD with
10% horse serum and correlates with MIC data for ocular
isolates from the literature of 0.06 to 1 lg/mL.26,27 A
concentration of AmpB, well above the MIC, is necessary to
ensure adequate dosing to the cornea considering that 7%
reaches the target tissues. Using serial dilutions of the stock
AmpB solution, we demonstrated that AmpB incorporated into
the peK hydrogels significantly reduced the growth of C.
albicans compared with no AmpB, independent of the
solution concentration over 18 hours. Generally, the gels
preincubated in AmpB and cultured under both normal growth
conditions (and when the PD was supplemented with 10%
horse serum) had a similar efficacy on C. albicans. When the
gels themselves were evaluated, it was clear that there was
minimal fungi growth on the gels or loosely attached to the
gels.
Once the gels had been removed from the wells, it was
important to evaluate whether any fungi remaining could
proliferate even if growth was low when the gels were present.
This could model the situation where the medicated lens was
removed from the eye without knowing if all the infection had
been eliminated. Over the subsequent 24 hours, minimal
fungal growth was observed in the wells that contained the
gels. These data suggest that the concentration of AmpB
attached to, and released from, the gels is fungicidal.
The approximate volume of tear fluid produced over 24
hours is 1.7 mL in a normal eye.28 When an eye is infected,
however, there is often a considerable increase in tear volume.
To mimic the dilution effect of the tear film, gels preincubated
in AmpB were stored in 3.4 mL sterile PBS for 24 hours. Over
this period, it is assumed that AmpB will diffuse out of the gel
into the media. After incubation, both the gels and the tear
fluid were evaluated for their antifungal activity. For the gels,
the growth of C. albicans in any of the wells (3 to 10 lg/mL)
after storage was significantly reduced compared with the
lowest concentration of AmpB (0.3 lg/mL). Similarly, aliquots
of the tear fluid from around these gels caused a significant
reduction in fungi growth. Evaluation of the tear fluid from
these gels demonstrated that only gels incubated in the greater
concentrations of AmpB (3 to 10 lg/mL) possessed a sufficient
concentration of AmpB to cause a significant reduction in
fungal growth. These data suggest that the effective antifungal
dose of AmpB had been released from these gels in the 24-hour
storage period but that this dose would be diluted too much in
a watery eye at the lowest incubation concentration of AmpB
(0.3 lg/mL). In higher AmpB loading situations, 24 hours in a
watery eye should allow sufficient release of AmpB to reduce
C. albicans growth in the eye, as well as on the gel surface. It
should be noted, however, that this model of tear film dilution
does not take into consideration the turnover of the tear fluid
and drainage of AmpB.
It is important to evaluate how much AmpB diffuses out of
the gels over time to help optimize the drug loading regime.
We demonstrated that after storage for all time points, the gel
released a clinically relevant dose of AmpB for 72 hours, only
falling below the MIC after 96 hours. These data demonstrate
that the gels are effective at delivering a clinically relevant dose
of AmpB. Furthermore, we could demonstrate that the dose of
AmpB delivered by the gel was stable enough after 48-hour
storage to kill C. albicans with a similar efficacy as a gel used
immediately after preincubation in AmpB. Effective treatment
of fungal keratitis will require the bandage contact lens to
maintain the level of AmpB against the cornea at a therapeutic
level to promote penetration of the drug into the corneal
stroma. These data suggest that the gel may be an effective
AmpB delivery device. It also suggests that the loading dose
could be tailored to release the appropriate dose at different
stages of the healing process.
The AmpB gel was also investigated for any cytotoxicity
toward the HCE-T cell line. The gels, with AmpB, as expected
and corroborated by previous work, were not cytotoxic
toward the HCE-T cell line.18 An appropriate next step will
be to investigate the AmpB gel in a diseased animal model or an
ex vivo model of bacterial keratitis.
CONCLUSIONS
This study demonstrated the potential of peK gels to act as a
drug delivery bandage contact lens. The gels have a proven
antifungal activity against C. albicans under normal growth
conditions and in the presence of horse serum after
preincubation with AmpB. A therapeutic amount of AmpB
was released from the gel for a period of 48 to 72 hours,
retaining its therapeutic fungicidal activity for at least 48 hours.
The AmpB gels also proved noncytotoxic to the HCE-T cell
line, further outlining its potential clinical use as a bandage
FIGURE 9. Cytotoxicity of AmpB gels toward the HCE-T cell line. Error
bars denote 6SD. N ¼ 8.
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contact lens to replace the laborious AmpB administration by
eye drops in the fight against fungal keratitis.
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